Quantcast

Latest Deep vein thrombosis Stories

2014-04-23 23:17:31

The DrugNews Center is the web’s largest source for prescription drug warnings, research and legal news. Visit http://www.DrugNews.net today. New York, NY (PRWEB) April 23, 2014 The birth control safety advocates at DrugNews.net are alerting women who have taken the oral contraceptives Yaz or Yasmin of updated legal news on the site. As settlements continue, the latest court records show the number of lawsuits alleging Yaz side effects has dropped for April*. DrugNews is a free resource...

2014-04-23 20:23:33

The realities of modern life can make people more susceptible to deep vein thrombosis, but the California Institute for Deep Venous Thrombosis offers effective solutions LOS ANGELES, April 23, 2014 /PRNewswire/ -- Due to our sedentary modern lifestyle, deep vein thrombosis (DVT) is a growing issue. DVT - a condition in which a person suffers from a blood clot in leg - is much more likely to occur if you're sitting still for a long time. With so many people sitting in front of television and...

2014-04-19 23:02:45

http://www.DrugNews.net is the web’s premier source for prescription drug warnings, research, side effects and legal news. Visit the DrugNews Center today. Chicago, IL (PRWEB) April 19, 2014 The prescription drug safety advocates at DrugNews.net are alerting patients taking the blood thinner Pradaxa of new information on the site. As the number of lawsuits alleging the drug caused internal bleeding continue to rise, its use has been expanded to include treatment of deep vein thrombosis...

2014-04-17 12:27:18

Surveyed MCOs Indicate That Tier Position of Pradaxa and Eliquis Unlikely to Change Even With Addition of VTE Treatment to Label, According to Findings from Decision Resources Group BURLINGTON, Mass., April 17, 2014 /PRNewswire/ -- Decision Resources Group finds that the novel oral anticoagulants (NOACs) will dramatically alter the treatment landscape for VTE treatment and secondary prophylaxis. Surveyed emergency room physicians and cardiologists indicate that they currently use...

2014-04-16 23:03:43

The Firm is actively investigating testosterone lawsuits on behalf of men who allegedly suffered heart attacks, strokes, pulmonary embolism, deep vein thrombosis or another cardiovascular injury after taking AndroGel or another “Low T” medication. New York, NY (PRWEB) April 16, 2014 A federal Panel has set a date next month to hear oral arguments on whether to transfer all pending and future AndroGel lawsuit (http://www.testosteronelawsuit2014.com/) filings to the U.S. District Court,...

2014-04-11 23:01:36

The Firm is evaluating Pradaxa lawsuits on behalf of individuals who allegedly suffered dangerous episodes of internal bleeding due to Pradaxa. New York, New York (PRWEB) April 11, 2014 As thousands of Pradaxa lawsuits (http://www.pradaxalawsuithelp.com/) continue to move forward in federal court, Bernstein Liebhard LLP notes that the U.S. Food & Drug Administration (FDA) has approved a new indication for the blood thinner. According to an April 7th announcement from Boehringer...

2014-04-08 23:01:01

Dr. Revana, at Northeast Houston Vein Center, is working to educate his peers on the challenging diagnosis of pelvic congestion syndrome as well as other conditions affecting veins. Humble, TX (PRWEB) April 08, 2014 Northeast Houston Vein Center recently began working to educate doctors on the issue of pelvic congestion syndrome (PCS) and other vein issues. Dr. Madaiah Revana is leading the effort on spreading the word about this tough condition. The facility now provides training to...

2014-04-08 12:31:49

Three pivotal trials showed PRADAXA as non-inferior to warfarin in reduction of DVT and PE recurrence; fourth pivotal trial showed PRADAXA reduced risk of recurrence by 92 percent compared to placebo RIDGEFIELD, Conn., April 8, 2014 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved Pradaxa(®) (dabigatran etexilate mesylate) for the treatment of deep venous thrombosis (DVT) and pulmonary embolism (PE) in...

2014-04-07 08:31:34

Three pivotal trials showed PRADAXA as non-inferior to warfarin in reduction of DVT and PE recurrence; fourth pivotal trial showed PRADAXA reduced risk of recurrence by 92 percent compared to placebo RIDGEFIELD, Conn., April 7, 2014 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved Pradaxa(®) (dabigatran etexilate mesylate) for the treatment of deep venous thrombosis (DVT) and pulmonary embolism (PE) in...

2014-04-01 23:31:09

The DrugNews Center is the web’s most comprehensive source for prescription drug warnings, research and legal news. Visit http://www.DrugNews.net today. Chicago, IL (PRWEB) April 01, 2014 The birth control safety center DrugNews.net is alerting women who have taken the oral contraceptives Yaz or Yasmin of updated legal news on the site. The most recent court records indicate the number of lawsuits alleging blood clot side effects dropped for the month of March*. DrugNews is a free...


Word of the Day
cock-a-hoop
  • Exultant; jubilant; triumphant; on the high horse.
  • Tipsy; slightly intoxicated.
This word may come from the phrase 'to set cock on hoop,' or 'to drink festively.' Its origin otherwise is unclear. A theory, according to the Word Detective, is that it's a 'transliteration of the French phrase 'coq a huppe,' meaning a rooster displaying its crest ('huppe') in a pose of proud defiance.' Therefore, 'cock-a-hoop' would 'liken a drunken man to a boastful and aggressive rooster.'
Related